These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 16368282)

  • 1. The cost-effectiveness analysis (CEA) is dependent on the quality of the NEPHRIC study.
    Hocher B
    Am Heart J; 2006 Jan; 151(1):e5; author reply e7. PubMed ID: 16368282
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost-effectiveness analysis (CEA) health economic point of view.
    Fricke FU
    Am Heart J; 2006 Jan; 151(1):e1; author reply e3. PubMed ID: 16368280
    [No Abstract]   [Full Text] [Related]  

  • 3. The safety and cost-effectiveness of low osmolar contrast media.
    Benness GT
    Med J Aust; 1991 Nov; 155(9):646-8. PubMed ID: 1943970
    [No Abstract]   [Full Text] [Related]  

  • 4. [Selection of contrast media: current status of understanding].
    Briguori C
    G Ital Cardiol (Rome); 2009 Feb; 10(2):79-87. PubMed ID: 19348144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute kidney injury with iodinated contrast.
    McCullough PA
    Crit Care Med; 2008 Apr; 36(4 Suppl):S204-11. PubMed ID: 18382195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case for nonionic contrast media--despite the high cost.
    Lieberman EB; Bashore TM
    J Crit Illn; 1992 Dec; 7(12):1853-4, 1860. PubMed ID: 10148097
    [No Abstract]   [Full Text] [Related]  

  • 7. Do benefits of contrast outweigh its costs?
    Cosgrove DO; Blomley MJ
    Diagn Imaging (San Franc); 1996 Sep; Suppl():AU31-2. PubMed ID: 10170152
    [No Abstract]   [Full Text] [Related]  

  • 8. Cost-effectiveness of hemofiltration to prevent contrast nephropathy in patients with chronic kidney disease.
    Klarenbach SW; Pannu N; Tonelli MA; Manns BJ
    Crit Care Med; 2006 Apr; 34(4):1044-51. PubMed ID: 16484907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iodinated contrast media and the kidney.
    Weisbord SD
    Rev Cardiovasc Med; 2008; 9 Suppl 1():S14-23. PubMed ID: 18418313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast media and nephropathy: findings from systematic analysis and Food and Drug Administration reports of adverse effects.
    Solomon R; Dumouchel W
    Invest Radiol; 2006 Aug; 41(8):651-60. PubMed ID: 16829749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iodinated contrast media and contrast-induced nephropathy: is there a preferred cost-effective agent?
    Sharma SK
    J Invasive Cardiol; 2008 May; 20(5):245-8. PubMed ID: 18460711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic evaluation of low osmolality contrast media.
    Hlatky MA
    J Am Coll Cardiol; 1993 Jun; 21(7):1710-1. PubMed ID: 8496541
    [No Abstract]   [Full Text] [Related]  

  • 13. Multimodality prevention of contrast-induced acute kidney injury.
    Briguori C; Airoldi F; Colombo A
    Am J Kidney Dis; 2008 Jun; 51(6):1068; author reply 1068-9. PubMed ID: 18501788
    [No Abstract]   [Full Text] [Related]  

  • 14. N-acetylcysteine for contrast nephropathy: more clinical science is required.
    Eddleston M; Goddard J; Bateman N
    Arch Intern Med; 2006 Aug 14-28; 166(15):1668-9; author reply 1669. PubMed ID: 16908804
    [No Abstract]   [Full Text] [Related]  

  • 15. Contrast media markdown.
    Bieze J
    Diagn Imaging (San Franc); 1996 Dec; 18(12):49-51, 54, 59. PubMed ID: 10163650
    [No Abstract]   [Full Text] [Related]  

  • 16. [Acute renal failure after venography].
    Castellanos Monedero JJ; Carreño Parrila A; Arrambarri Segura M; Carros Tortosa G
    Nefrologia; 2008; 28(3):357-8. PubMed ID: 18590512
    [No Abstract]   [Full Text] [Related]  

  • 17. Cost-effectiveness analysis (CEA) of intravenous urography (IVU) and unenhanced multidetector computed tomography (MDCT) for initial investigation of suspected acute ureterolithiasis.
    Eikefjord E; Askildsen JE; Rørvik J
    Acta Radiol; 2008 Mar; 49(2):222-9. PubMed ID: 18300151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The safety and cost-effectiveness of low osmolar contrast media.
    Proudfoot AD
    Med J Aust; 1991 Jul; 155(2):136. PubMed ID: 1906974
    [No Abstract]   [Full Text] [Related]  

  • 19. Multimodality prevention of contrast-induced acute kidney injury.
    McCullough PA
    Am J Kidney Dis; 2008 Feb; 51(2):169-72. PubMed ID: 18215694
    [No Abstract]   [Full Text] [Related]  

  • 20. Prophylactic hemodialysis for the prevention of contrast-induced nephropathy after coronary angiography.
    Marenzi G
    Nat Clin Pract Nephrol; 2008 Mar; 4(3):130-1. PubMed ID: 18059387
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.